Arcalyst and Prednisone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arcalyst and Prednisone. Common interactions include abdominal pain upper among females and asthenia among males.

The phase IV clinical study analyzes what interactions people who take Arcalyst and Prednisone have. It is created by eHealthMe based on reports of 21 people who take Arcalyst and Prednisone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 06, 2022

21 people who take Arcalyst and Prednisone together, and have interactions are studied.


What is Arcalyst?

Arcalyst has active ingredients of rilonacept. eHealthMe is studying from 242 Arcalyst users for its effectiveness, alternative drugs and more.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 531,290 Prednisone users for its effectiveness, alternative drugs and more.

Number of Arcalyst and Prednisone reports submitted per year:

Arcalyst and Prednisone drug interactions.

Common Arcalyst and Prednisone drug interactions by gender *:

female:

  1. Abdominal pain upper
  2. Fatigue
  3. Injection site erythema
  4. Injection site reaction
  5. Insomnia
  6. Lung hyperinflation
  7. Pain
  8. Palpitations
  9. Aphasia
  10. Blood pressure increased

male:

  1. Asthenia
  2. Coronary artery occlusion

Common Arcalyst and Prednisone drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Juvenile arthritis
  2. Laryngitis viral
  3. Myofascitis
  4. Polyarthritis

20-29:

n/a

30-39:

  1. Coronary artery occlusion

40-49:

  1. Exophthalmos
  2. Eye inflammation
  3. Ocular discomfort

50-59:

  1. Eye inflammation
  2. Somnolence
  3. Swelling face
  4. Visual impairment

60+:

  1. Hypoaesthesia
  2. Asthenia
  3. Discomfort
  4. Dizziness
  5. Dyspnoea
  6. Fall
  7. Fluid retention
  8. Headache
  9. Heart rate increased
  10. Hemiparesis

Common conditions people have *:

  1. Pericarditis (inflammation of the pericardium): 14 people, 66.67%
  2. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Arcalyst and Prednisone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Arcalyst and Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prednisone side effects:

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prednisone interactions:

Browse all interactions between Prednisone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rilonacept and prednisone (the active ingredients of Arcalyst and Prednisone, respectively), and Arcalyst and Prednisone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Arcalyst and Prednisone.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: